|
Exa users will have access to LVivo Toolbox to perform automated and quantified analysis of the left ventricle to detect cardiac dysfunction in COVID-19 patients in the echo lab and on the frontline, as recommended by the
Furthermore, Exa users can now perform and bill for reimbursement for myocardial strain imaging when using LVivo Strain.
AI-based solutions such as LVivo Cardiac Toolbox are increasingly being adopted to automate workflow and assist clinicians with objective clinical indications to support their decision-making process. In echocardiography, AI-based analysis tools may also help reduce variability and increase efficiency throughout the analysis process.
Providing these advanced echocardiography tools on Exa enables users to free up the ultrasound system for patient exams rather than performing manual and time-consuming analysis. The LVivo AI-based Cardiac Toolbox is accessible in one click. With Exa Server-Side Rendering, images are instantly available with zero lag time from any Web-enabled computer, including prior studies.
“In the new COVID-19 normal, sonographers and echocardiographers are facing a new challenge in coping with increased procedures in the echo lab while supporting patients on the frontlines,” says
The platform includes:
- LVivo EF - Auto Ejection Fraction analysis, a key indicator of cardiac function, essential in cases of heart failure, shock, chest pain, as well as cardiac and surgical procedures.
- LVivo Strain - Auto evaluation of segmental and global Left Ventricle (LV) strain, an early indicator for reduced
LV function that is especially important in patients undergoing chemotherapy. Strain analysis is now a reimbursable exam in the US. - LVivo SWM - Auto evaluation of the Segmental Wall Motion of the 17 muscle segments of the left ventricle. LVivo SWM provides information about the contraction of each of the segments and the global contractility. Identifying wall motion abnormalities is especially important during and after coronary events.
Konica Minolta and DiA will demonstrate LVivo Toolbox during the upcoming
About
About DiA Imaging Analysis
DiA Imaging Analysis is a leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. The company’s LVivo product line for cardiac and abdominal auto analysis allows clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency and accuracy. DiA serves thousands of end-users worldwide. For additional information, please visit http://www.dia-analysis.com.
Media Contacts: | |
For | For DiA Imaging Analysis |
Mary Beth Massat | Edith Schlanger |
Massat Media | Marketing Manager |
224.578.2388 | +972-77-7648318 |
www.konicaminolta.com/medicalusa | www.dia-analysis.com |
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b4a69c25-dbff-49d2-8611-c9c4944e9f80
Source:
2020 GlobeNewswire, Inc., source